Changes in morphology and function of adrenal cortex in mice fed a high-fat diet

International Journal of Obesity

Volumn 39, Issue 2, 2015, Pages 321-330

  Swierczynska, M M ^a,b,c   Mateska, I ^a,b   Peitzsch, M ^b   Bornstein, S R ^b   Chavakis, T ^b   Eisenhofer, G ^b   Lamounier Zepter, V ^b   Eaton, S ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; SONIC HEDGEHOG PROTEIN; STEROID HORMONE; CORTICOSTEROID; CORTICOSTERONE; GLI PROTEIN, MOUSE; HEAT SHOCK PROTEIN; KRUPPEL LIKE FACTOR; SHH PROTEIN, MOUSE;

ADRENAL CORTEX; ADRENAL CORTEX FUNCTION; ADRENAL GLAND; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DIET INDUCED OBESITY; FEEDING; GENE EXPRESSION; LIPID DIET; MORPHOLOGY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; STEM CELL; STEROIDOGENESIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALIA; ERINACEIDAE; MUS;

ADRENAL CORTEX; ADRENAL CORTEX HORMONES; ANIMALS; CELLS, CULTURED; CORTICOSTERONE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; HEAT-SHOCK PROTEINS; HEDGEHOG PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY;

EID: 84922617812     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.102     Document Type: Article

References (53)

1. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643.
2. King B, Jiang Y, Su X, Xu J, Xie L, Standard J et al. Weight control, endocrine hormones and cancer prevention. Exp Biol Med (Maywood) 2013; 238: 502-508.
3. Krug AW, Ehrhart-Bornstein M. Adrenocortical dysfunction in obesity and the metabolic syndrome. Horm Metab Res 2008; 40: 515-517.
4. Pasquali R, Vicennati V, Gambineri A. Adrenal and gonadal function in obesity. J Endocrinol Invest 2002; 25: 893-898.
5. Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab 2007; 292: E654-E667.
6. Sowers JR, Whaley-Connell A, Epstein M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150: 776-783.
7. Pasquali R, Vicennati V. Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Int J Obes Relat Metab Disord 2000; 24: S47-S49.
8. Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann NY Acad Sci 2006; 1083: 111-128.
9. Glass AR, Burman KD, Dahms WT, Boehm TM. Endocrine function in human obesity. Metab Clin Exp 1981; 30: 89-104.
10. Muller-Fielitz H, Lau M, Johren O, Stellmacher F, Schwaninger M, Raasch W. Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism. Br J Pharmacol 2012; 166: 2417-2429.
11. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000; 141: 560-563.
12. Naeser P. Function of the adrenal cortex in obese-hyperglycemic mice (gene symbol ob). Diabetologia 1974; 10: 449-453.
13. Northcott CA, Fink GD, Garver H, Haywood JR, Laimon-Thomson EL, McClain JL et al. The development of hypertension and hyperaldosteronism in a rodent model of life-long obesity. Endocrinology 2012; 153: 1764-1773.
14. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010; 46: 212-223.
15. Roberge C, Carpentier AC, Langlois MF, Baillargeon JP, Ardilouze JL, Maheux P et al. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. Am J Physiol Endocrinol Metab 2007; 293: E1465-E1478.
16. Thomson SP, Stump CS, Kurukulasuriya LR, Sowers JR. Adrenal steroids and the metabolic syndrome. Curr Hypertens Rep 2007; 9: 512-519.
17. Cassano AE, White JR, Penraat KA, Wilson CD, Rasmussen S, Karatsoreos IN. Anatomic, hematologic, and biochemical features of C57BL/6NCrl mice maintained on chronic oral corticosterone. Comp Med 2012; 62: 348-360.
18. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 2008; 19: 175-180.
19. Willenberg HS, Schinner S, Ansurudeen I. New mechanisms to control aldosterone synthesis. Horm Metab Res Metab 2008; 40: 435-441.
20. Wang M. The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr Metab 2005; 2: 3.
21. Lamounier-Zepter V, Ehrhart-Bornstein M, Bornstein SR. Metabolic syndrome and the endocrine stress system. Horm Metab Res 2006; 38: 437-441.
22. Wolkersdorfer GW, Bornstein SR. Tissue remodelling in the adrenal gland. Biochem Pharmacol 1998; 56: 163-171.
23. Huang CC, Miyagawa S, Matsumaru D, Parker KL, Yao HH. Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog. Endocrinology 2010; 151: 1119-1128.
24. King P, Paul A, Laufer E. Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc Natl Acad Sci USA 2009; 106: 21185-21190.
25. Ching S, Vilain E. Targeted disruption of Sonic Hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis 2009; 47: 628-637.
26. Wood MA, Acharya A, Finco I, Swonger JM, Elston MJ, Tallquist MD et al. Fetal adrenal capsular cells serve as progenitor cells for steroidogenic and stromal adrenocortical cell lineages in M. musculus. Development 2013; 140: 4522-4532.
27. Laufer E, Kesper D, Vortkamp A, King P. Sonic hedgehog signaling during adrenal development. Mol Cell Endocrinol 2012; 351: 19-27.
28. Guasti L, Cavlan D, Cogger K, Banu Z, Shakur A, Latif S et al. Dlk1 upregulates Gli1 expression in male rat adrenal capsule cells through the activation of beta1 integrin and ERK1-2. Endocrinology 2013; 154: 4675-4684.
29. McGinnis R, Walker J, Margules D, Aird F, Redei E. Dysregulation of the hypothalamus-pituitary-adrenal axis in male and female, genetically obese (ob/ob) mice. J Neuroendocrinol 1992; 4: 765-771.
30. Naeser P. In vitro release of corticosteroids from adrenal glands of obesehyperglycemic mice (gene symbol ob). Acta Physiol Scand 1974; 92: 175-180.
31. Bornstein SR, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum WA. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 1997; 46: 1235-1238.
32. Kruse M, Bornstein SR, Uhlmann K, Paeth G, Scherbaum WA. Leptin down-regulates the steroid producing system in the adrenal. Endocr Res 1998; 24: 587-590.
33. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007; 15: 798-808.
34. Hinchliffe E, Carter S, Owen LJ, Keevil BG. Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 2013; 913-914: 19-23.
35. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9: 676-682.
36. Kamentsky L, Jones TR, Fraser A, Bray MA, Logan DJ, Madden KL et al. Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics 2011; 27: 1179-1180.
37. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32: 81-151.
38. Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci 2010; 11: 710-718.
39. Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M. ACTH-receptor expression, regulation and role in adrenocortial tumor formation. Eur J Endocrinol 2001; 144: 199-206.
40. Wood MA, Hammer GD. Adrenocortical stem and progenitor cells: unifying model of two proposed origins. Mol Cell Endocrinol 2011; 336: 206-212.
41. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013; 5: 1218-1240.
42. Palm W, Swierczynska MM, Kumari V, Ehrhart-Bornstein M, Bornstein SR, Eaton S. Secretion and signaling activities of lipoprotein-associated hedgehog and non-sterol-modified hedgehog in flies and mammals. PLoS Biology 2013; 11: e1001505.
43. Nachtergaele S, Mydock LK, Krishnan K, Rammohan J, Schlesinger PH, Covey DF et al. Oxysterols are allosteric activators of the oncoprotein Smoothened. Nat Chem Biol 2012; 8: 211-220.
44. Khaliullina H, Panakova D, Eugster C, Riedel F, Carvalho M, Eaton S. Patched regulates Smoothened trafficking using lipoprotein-derived lipids. Development 2009; 136: 4111-4121.
45. Bijlsma MF, Spek CA, Zivkovic D, van de Water S, Rezaee F, Peppelenbosch MP. Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol 2006; 4: e232.
46. Khaliullina H, Bilgin M, Sampaio JL, Shevchenko A, Eaton S. Lipoproteins carry endocannabinoids that inhibit the Hedgehog pathway. bioRxiv 2013; doi:10.1101/000570.
47. Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 2008; 51: 1356-1367.
48. Sewer MB, Dammer EB, Jagarlapudi S. Transcriptional regulation of adrenocortical steroidogenic gene expression. Drug Metab Rev 2007; 39: 371-388.
49. Schinner S, Willenberg HS, Krause D, Schott M, Lamounier-Zepter V, Krug AW et al. Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. Int J Obes 2007; 31: 864-870.
50. Krug AW, Vleugels K, Schinner S, Lamounier-Zepter V, Ziegler CG, Bornstein SR et al. Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II-sensitization in human adrenocortical cells. Int J Obes 2007; 31: 1605-1616.
51. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 2003; 100: 14211-14216.
52. Lavoie HA, King SR. Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Exp Biol Med (Maywood) 2009; 234: 880-907.
53. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591.